Blood test may lead to targeted therapy for prostate cancer
"A blood test has been developed that could help target treatment for men with advanced prostate cancer," BBC News reports. The test could help identify men unlikely to respond to drugs such as enzalutamide. Enzalutamide and abiraterone are additional treatments for men for whom standard hormonal treatment has not worked, or has stopped working. Treatment
Most Commented